Procter & Gamble Company (The) $PG Shares Purchased by Arlington Partners LLC

Arlington Partners LLC raised its holdings in Procter & Gamble Company (The) (NYSE:PGFree Report) by 16.9% during the third quarter, HoldingsChannel.com reports. The firm owned 31,341 shares of the company’s stock after buying an additional 4,523 shares during the period. Arlington Partners LLC’s holdings in Procter & Gamble were worth $4,816,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in PG. Halbert Hargrove Global Advisors LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter worth about $25,000. Signature Resources Capital Management LLC grew its stake in Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares in the last quarter. Corundum Trust Company INC acquired a new stake in Procter & Gamble during the third quarter valued at approximately $32,000. Mid American Wealth Advisory Group Inc. bought a new position in Procter & Gamble during the 2nd quarter worth approximately $34,000. Finally, RMG Wealth Management LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $37,000. Institutional investors own 65.77% of the company’s stock.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

Procter & Gamble Stock Down 0.1%

Shares of Procter & Gamble stock opened at $144.55 on Friday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $179.99. The stock’s fifty day moving average is $144.72 and its 200-day moving average is $151.05. The firm has a market capitalization of $337.77 billion, a PE ratio of 21.10, a price-to-earnings-growth ratio of 4.88 and a beta of 0.39. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same quarter in the previous year, the business earned $1.93 earnings per share. The firm’s revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is presently 61.61%.

Insiders Place Their Bets

In other news, CAO Matthew W. Janzaruk sold 725 shares of the company’s stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $149.57, for a total value of $108,438.25. Following the transaction, the chief accounting officer owned 979 shares in the company, valued at $146,429.03. This represents a 42.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. UBS Group reduced their price objective on Procter & Gamble from $176.00 to $161.00 and set a “buy” rating on the stock in a research note on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, December 29th. Raymond James Financial dropped their price objective on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. TD Cowen lowered their target price on Procter & Gamble from $168.00 to $150.00 and set a “buy” rating for the company in a report on Thursday, January 8th. Finally, Barclays set a $155.00 price target on shares of Procter & Gamble in a report on Friday. Fifteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $168.73.

View Our Latest Report on PG

Procter & Gamble Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.